Biomarkers and translational research and precision medicine

7P - Independent validation of HER2DX ERBB2 mRNA score to predict HER2-positive (HER2+), HER2-low and HER2-0 status in breast cancer (ID 227)

Presentation Number
7P
Speakers
  • Esther Sanfeliu Torres (Barcelona, Spain)
Authors
  • Esther Sanfeliu Torres (Barcelona, Spain)
  • Guillermo Villacampa (Barcelona, Spain)
  • Tomas Pascual (Barcelona, Spain)
  • Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
  • Maria Jesus Vidal Losada (Barcelona, Spain)
  • Meritxell Bellet Ezquerra (Barcelona, Spain)
  • Blanca Gonzalez-Farre (Barcelona, Spain)
  • Joan A. Puig-Butille (Barcelona, Spain)
  • Pedro Jares (Barcelona, Spain)
  • Sonia Pernas Simon (L'Hospitalet de Llobregat, Spain)
  • Coralia Bueno Muiño (Alcorcon, Ma, Spain)
  • Miguel Martin (Madrid, Spain)
  • Paolo Tarantino (Boston, MA, United States of America)
  • Adrienne G. Waks (Boston, MA, United States of America)
  • Elizabeth A. Mittendorf (Boston, United States of America)
  • Sara M. Tolaney (Boston, MA, United States of America)
  • Javier Cortes (Madrid and Barcelona, Spain)
  • Antonio Llombart Cussac (Valencia, Spain)
  • Aleix Prat (Barcelona, Spain)
  • Fara Brasó-Maristany (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine